Cocrystal Pharma (COCP) Total Current Liabilities (2010 - 2026)
Cocrystal Pharma (COCP) posted Total Current Liabilities of $2.2 million for Q1 2026, up 0.86% sequentially from $2.2 million in Q4 2025, and up 15.43% YoY from $1.9 million in Q1 2025.
Cocrystal Pharma (COCP) Total Current Liabilities (2010 - 2026) Analysis & Trends
Cocrystal Pharma has reported Total Current Liabilities for 16 years, with the latest figure at $2.2 million in Q1 2026.
- Quarterly Total Current Liabilities rose 15.43% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (up 15.43% YoY) and the FY2025 annual result came in at $2.2 million, down 8.98% from the prior year.
- Total Current Liabilities advanced to $2.2 million in Q1 2026 per COCP's latest filing, from $2.2 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $3.3 million in Q4 2023 and troughed at $1.2 million in Q4 2022.
- A 5-year average of $2.1 million and a median of $1.9 million in 2024 frame the typical range for Total Current Liabilities.
- The widest YoY moves for Total Current Liabilities: up 168.26% in 2023, down 43.58% in 2023.
- Over 5 years, Total Current Liabilities stood at $1.2 million in 2022, then surged by 168.26% to $3.3 million in 2023, then slipped by 25.57% to $2.4 million in 2024, then declined by 8.98% to $2.2 million in 2025, then grew by 0.86% to $2.2 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $2.2 million, $2.2 million, and $1.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 438.74 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 630.93 Mn |
| 10 | Cocrystal Pharma | 15.65 Mn | 13.33 Mn | - | 2.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.62 Mn |
| Mar 31, 2026 | 2.23 Mn |
| Dec 31, 2025 | 2.21 Mn |
| Sep 30, 2025 | 1.52 Mn |
| Jun 30, 2025 | 1.83 Mn |
| Mar 31, 2025 | 1.93 Mn |
| Dec 31, 2024 | 2.43 Mn |
| Sep 30, 2024 | 1.95 Mn |
| Jun 30, 2024 | 2.65 Mn |
| Mar 31, 2024 | 2.38 Mn |
| Dec 31, 2023 | 3.26 Mn |
| Sep 30, 2023 | 1.92 Mn |
| Jun 30, 2023 | 1.59 Mn |
| Mar 31, 2023 | 3.15 Mn |
| Dec 31, 2022 | 1.22 Mn |
| Sep 30, 2022 | 1.62 Mn |
| Jun 30, 2022 | 2.81 Mn |
| Mar 31, 2022 | 1.56 Mn |
| Dec 31, 2021 | 1.55 Mn |
| Sep 30, 2021 | 1.23 Mn |